HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Astaxanthin reduces matrix metalloproteinase-9 expression and activity in the brain after experimental subarachnoid hemorrhage in rats.

Abstract
We have previously shown that astaxanthin (ATX) reduces the blood-brain barrier (BBB) disruption and neurovascular dysfunction following subarachnoid hemorrhage (SAH) insults. However, the underlying mechanisms remain unclear. It is known that the matrix metalloproteinases (MMPs), especially matrix metalloproteinase-9 (MMP-9) plays a crucial role in the pathogenesis of secondary brain injury after SAH. And ATX has the ability to regulate MMP-9 in other models. Herein, we investigated whether ATX could ameliorate MMP-9 activation and expression in a rat model of SAH. A total of 144 rats were randomly divided into the following groups: control group (n=36), SAH group (n=36), SAH+vehicle group (n=36), and SAH+ATX group (n=36). The SAH model was induced by injection of 0.3 ml autologous blood into the prechiasmatic cistern. ATX (20 μl of 0.1 mmol) or vehicle was administered intracerebroventricularly 30 min after SAH induction. Mortality, neurological function, brain edema and blood-brain barrier (BBB) permeability were measured at 24 and 72 h after SAH. Biochemical and zymographic methods were used to analyze MMP-9 expression and activity in brain samples. Immunohistochemistry and terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) staining were also evaluated at 24h. Our data indicated that ATX could significantly reduce the expression and activity of MMP-9, leading to the amelioration of brain edema, BBB impairment, neurological deficits and TUNEL-positive cells at 24h but not 72 h after SAH. The ATX-mediated down-regulation of MMP-9 was correlated with the decreased levels of IL-1β, TNF-α, oxidative stress, activated microglia and infiltrating neutrophils. These results suggest that the neurovascular protection of ATX in SAH is partly associated with the inhibition of MMP-9 expression and activity.
AuthorsXiang-Sheng Zhang, Xin Zhang, Qing-Rong Zhang, Qi Wu, Wei Li, Tian-Wei Jiang, Chun-Hua Hang
JournalBrain research (Brain Res) Vol. 1624 Pg. 113-124 (Oct 22 2015) ISSN: 1872-6240 [Electronic] Netherlands
PMID26210617 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 Elsevier B.V. All rights reserved.
Chemical References
  • Xanthophylls
  • Malondialdehyde
  • astaxanthine
  • Matrix Metalloproteinase 9
Topics
  • Analysis of Variance
  • Animals
  • Blood-Retinal Barrier (growth & development, physiopathology)
  • Brain (drug effects, enzymology)
  • Brain Edema (etiology, prevention & control)
  • Capillary Permeability (drug effects)
  • Disease Models, Animal
  • Gene Expression Regulation, Enzymologic (drug effects)
  • In Situ Nick-End Labeling
  • Male
  • Malondialdehyde (metabolism)
  • Matrix Metalloproteinase 9 (metabolism)
  • Neurologic Examination
  • Rats
  • Rats, Sprague-Dawley
  • Subarachnoid Hemorrhage (drug therapy, pathology)
  • Time Factors
  • Xanthophylls (pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: